Complex Endovascular Repair for Genetically-Triggered Aortic Disease in Italy (CENTRAL Multicentric Registry)

BACKGROUND: The role of fenestrated and branched endovascular aortic repair (F/BEVAR) in patients with genetically triggered aortic disease and connective tissue disorders (CTDs) remains controversial due to concerns regarding long-term durability and disease progression. This multicenter study aimed to evaluate early and mid-term outcomes of F/BEVAR in patients with CTD treated for thoracoabdominal aortic aneurysms (TAAAs). METHODS: This retrospective multicenter study included all consecutive CTD patients with genetically triggered aortic disease undergoing F/BEVAR for TAAA between 2013 and 2024 at 12 Italian centers. Primary endpoints were technical and clinical success, early and mid-term survival, and major adverse events (MAEs). Secondary endpoints included target vessel instability and the need for reintervention. Survival and freedom from adverse events were estimated using Kaplan-Meier analysis. RESULTS: A total of 45 CTD patients (62.2% male; mean age, 56.4 ± 11.7 years) were treated with F/BEVAR. Marfan syndrome was present in 80% of patients, and 68.9% were treated for post-dissection TAAA. Most patients presented with type II TAAA (91.1%), and 88.9% had undergone at least 1 prior aortic operation. Technical and clinical success were achieved in 86.6% and 82.2% of cases, respectively. Early mortality and MAEs occurred in 4.4% of patients. During a mean clinical follow-up of 35.0 ± 33.9 months, estimated overall survival at 12, 24, and 36 months was 90.0%, 86.7%, and 79.2%, respectively, with no aorta-related deaths. At a mean imaging follow-up of 33.8 ± 32.2 months, target vessel patency was 98.8%. Target vessel instability occurred in 40% of patients, and 42.2% required 1 or more secondary interventions. Reintervention-free survival at 12, 24, and 36 months was 75.6%, 72.4%, and 59.0%, respectively. No baseline, anatomic, or procedural variable independently predicted late adverse outcomes. CONCLUSIONS: In this cohort of CTD patients, predominantly treated in complex redo settings, F/BEVAR demonstrated acceptable early and mid-term outcomes. Late adverse events and reinterventions were frequent but consistent with the natural history of CTD-related aortic disease and were not driven by identifiable baseline factors. These findings support the role of F/BEVAR as a valuable approach within a comprehensive, lifelong management strategy for CTD patients rather than as a definitive alternative to open surgery (OS).Clinical ImpactPatients with genetically triggered aortic disease often require multiple interventions throughout their lifetime because of the progressive nature of the underlying aortopathy. In this context, fenestrated/branched endovascular aortic repair (F/BEVAR) should not be considered an alternative to open surgery, but rather a complementary approach within the long-term management of these patients. This multicenter study provides one of the largest dedicated experiences with F/BEVAR in this challenging population, showing that acceptable early and mid-term outcomes can be achieved even in complex redo and post-dissection settings. These findings support the integration of endovascular techniques into individualized, lifelong aortic treatment strategies at experienced centers, acknowledging the need for continued surveillance and secondary interventions.

Authors

Institutions

Publication Details

Journal
Journal of Endovascular Therapy
Published
2026-11-20
DOI
https://doi.org/10.1177/15266028261504286
Primary Topic
Aortic Disease and Treatment Approaches
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Complex Endovascular Repair for Genetically-Triggered Aortic Disease in Italy (CENTRAL Multicentric Registry)

Yamume Tshomba, Rocco Giudice, Mauro Gargiulo, Francesco Squizzato et al.
Journal of Endovascular Therapy
Aortic Disease and Treatment Approaches
article

Complex Endovascular Repair for Genetically-Triggered Aortic Disease in Italy (CENTRAL Multicentric Registry)

Yamume Tshomba, Rocco Giudice, Mauro Gargiulo, Francesco Squizzato, Giacomo Isernia, Enrico Gallitto, Giovanni Pratesi, F Valente, Eugenio Martelli, Martina Bastianon, Germano Melissano, Gianmarco de Donato, Sandro Lepidi, Gioele Simonte, Luca Bertoglio, Andrea Melloni, Mario D’Oria, Ciro Ferrer, Davide Esposito, Gian Franco Veraldi, Stefano Bonardelli, Michele Piazza, Carlo Coscarella, Luca Mezzetto, Giovanni Tinelli, Antonio Cappiello, Fabio Massimo Oddi, Andrea Kahlberg, Roberto Chiesa, Marta Minucci, Michele Antonello, Gianbattista Parlani, For CENTRAL Study Collaborators
article en

Abstract

BACKGROUND: The role of fenestrated and branched endovascular aortic repair (F/BEVAR) in patients with genetically triggered aortic disease and connective tissue disorders (CTDs) remains controversial due to concerns regarding long-term durability and disease progression. This multicenter study aimed to evaluate early and mid-term outcomes of F/BEVAR in patients with CTD treated for thoracoabdominal aortic aneurysms (TAAAs). METHODS: This retrospective multicenter study included all consecutive CTD patients with genetically triggered aortic disease undergoing F/BEVAR for TAAA between 2013 and 2024 at 12 Italian centers. Primary endpoints were technical and clinical success, early and mid-term survival, and major adverse events (MAEs). Secondary endpoints included target vessel instability and the need for reintervention. Survival and freedom from adverse events were estimated using Kaplan-Meier analysis. RESULTS: A total of 45 CTD patients (62.2% male; mean age, 56.4 ± 11.7 years) were treated with F/BEVAR. Marfan syndrome was present in 80% of patients, and 68.9% were treated for post-dissection TAAA. Most patients presented with type II TAAA (91.1%), and 88.9% had undergone at least 1 prior aortic operation. Technical and clinical success were achieved in 86.6% and 82.2% of cases, respectively. Early mortality and MAEs occurred in 4.4% of patients. During a mean clinical follow-up of 35.0 ± 33.9 months, estimated overall survival at 12, 24, and 36 months was 90.0%, 86.7%, and 79.2%, respectively, with no aorta-related deaths. At a mean imaging follow-up of 33.8 ± 32.2 months, target vessel patency was 98.8%. Target vessel instability occurred in 40% of patients, and 42.2% required 1 or more secondary interventions. Reintervention-free survival at 12, 24, and 36 months was 75.6%, 72.4%, and 59.0%, respectively. No baseline, anatomic, or procedural variable independently predicted late adverse outcomes. CONCLUSIONS: In this cohort of CTD patients, predominantly treated in complex redo settings, F/BEVAR demonstrated acceptable early and mid-term outcomes. Late adverse events and reinterventions were frequent but consistent with the natural history of CTD-related aortic disease and were not driven by identifiable baseline factors. These findings support the role of F/BEVAR as a valuable approach within a comprehensive, lifelong management strategy for CTD patients rather than as a definitive alternative to open surgery (OS).Clinical ImpactPatients with genetically triggered aortic disease often require multiple interventions throughout their lifetime because of the progressive nature of the underlying aortopathy. In this context, fenestrated/branched endovascular aortic repair (F/BEVAR) should not be considered an alternative to open surgery, but rather a complementary approach within the long-term management of these patients. This multicenter study provides one of the largest dedicated experiences with F/BEVAR in this challenging population, showing that acceptable early and mid-term outcomes can be achieved even in complex redo and post-dissection settings. These findings support the integration of endovascular techniques into individualized, lifelong aortic treatment strategies at experienced centers, acknowledging the need for continued surveillance and secondary interventions.

Journal of Endovascular Therapy
University of Siena (IT), University of Rome Tor Vergata (IT), University of Verona (IT), University of Padua (IT), University of Trieste (IT), Vita-Salute San Raffaele University (IT), University of Perugia (IT), Azienda Ospedaliera San Giovanni Addolorata (IT), Agostino Gemelli University Polyclinic (IT), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), IRCCS Ospedale San Raffaele (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), IRCCS Azienda Ospedaliera Metropolitana (IT), University of Genoa (IT), University of Bologna (IT)
Aortic Disease and Treatment Approaches
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon